Insights

Innovative AI Approach Abzu's proprietary explainable AI, the QLattice®, positions it as a leader in in silico disease understanding and drug design, offering a compelling value proposition for pharmaceutical and biotech companies seeking advanced, data-driven R&D solutions.

Growing Funding Support With a total funding of €13.3 million and recent investments, Abzu demonstrates strong financial backing that can be leveraged to expand product offerings, scale operations, and deepen collaborations within the pharmaceutical industry.

Industry Recognition Recognition from Gartner® and awards like the 2023 Best HealthTech Nordic Award enhance Abzu’s credibility, making it an attractive partner for organizations looking for cutting-edge, trusted AI technology in healthcare.

Market Positioning Positioned alongside notable AI companies with similar offerings but smaller team size and revenue, Abzu presents a niche opportunity for early adopters in biotech seeking innovative AI-driven tools for drug discovery.

Targeted Collaboration With offices in Copenhagen and Barcelona and a focus on pharma, biotech, and research institutions, there are ample opportunities to explore strategic partnerships and client engagements across European markets focused on advanced AI-based drug research.

Abzu Tech Stack

Abzu uses 8 technology products and services including Unpkg, Shopify, D3.js, and more. Explore Abzu's tech stack below.

  • Unpkg
    Content Delivery Network
  • Shopify
    E-commerce
  • D3.js
    Javascript Graphics
  • Chart.js
    Javascript Graphics
  • Modernizr
    Javascript Libraries
  • HubSpot CRM
    Sales
  • HSTS
    Security
  • Essential Addons for Elementor
    Web Platform Extensions

Media & News

Abzu's Email Address Formats

Abzu uses at least 1 format(s):
Abzu Email FormatsExamplePercentage
First.Last@abzu.aiJohn.Doe@abzu.ai
46%
First.Middle@abzu.aiJohn.Michael@abzu.ai
4%
First.Last@abzu.aiJohn.Doe@abzu.ai
46%
First.Middle@abzu.aiJohn.Michael@abzu.ai
4%

Frequently Asked Questions

Where is Abzu's headquarters located?

Minus sign iconPlus sign icon
Abzu's main headquarters is located at 1 Orient Plads Nordhavn, Hovedstaden 2150 Denmark. The company has employees across 3 continents, including EuropeAsiaSouth America.

What is Abzu's stock symbol?

Minus sign iconPlus sign icon
Abzu is a publicly traded company; the company's stock symbol is ABZUF.

What is Abzu's official website and social media links?

Minus sign iconPlus sign icon
Abzu's official website is abzu.ai and has social profiles on LinkedInCrunchbase.

What is Abzu's SIC code NAICS code?

Minus sign iconPlus sign icon
Abzu's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abzu have currently?

Minus sign iconPlus sign icon
As of February 2026, Abzu has approximately 24 employees across 3 continents, including EuropeAsiaSouth America. Key team members include Cfo: K. S.Chief Operating Officer: M. J.Head Of Rna Therapeutics: D. T.. Explore Abzu's employee directory with LeadIQ.

What industry does Abzu belong to?

Minus sign iconPlus sign icon
Abzu operates in the Biotechnology Research industry.

What technology does Abzu use?

Minus sign iconPlus sign icon
Abzu's tech stack includes UnpkgShopifyD3.jsChart.jsModernizrHubSpot CRMHSTSEssential Addons for Elementor.

What is Abzu's email format?

Minus sign iconPlus sign icon
Abzu's email format typically follows the pattern of First.Last@abzu.ai. Find more Abzu email formats with LeadIQ.

How much funding has Abzu raised to date?

Minus sign iconPlus sign icon
As of February 2026, Abzu has raised $7.9M in funding. .

When was Abzu founded?

Minus sign iconPlus sign icon
Abzu was founded in 2018.

Abzu

Biotechnology ResearchHovedstaden, Denmark11-50 Employees

Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D.

Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.

Section iconCompany Overview

Headquarters
1 Orient Plads Nordhavn, Hovedstaden 2150 Denmark
Website
abzu.ai
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ABZUF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $7.9M

    Abzu has raised a total of $7.9M of funding over 2 rounds. .

  • $1M

    Abzu's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $7.9M

    Abzu has raised a total of $7.9M of funding over 2 rounds. .

  • $1M

    Abzu's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.